Search Press releases Keywords From To 28 Apr 2021 UCB Announces PDUFA Date for Bimekizumab Read More 23 Apr 2021 Acquisitions of own shares and disposals of own shares Read More 23 Apr 2021 UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021 Read More 23 Apr 2021 The New England Journal of Medicine Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis Read More 22 Apr 2021 UCB’s zilucoplan shows no relevant effect in immune-mediated necrotizing myopathy (IMNM) Read More 20 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More Pagination First page Previous page Previous … Page 56 Page 57 Page 58 Page 59 Current page 60 Page 61 Page 62 Page 63 Page 64 … Page 60 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
